MYCARI · MG0003
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase III randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rozanolixizumab in adult patients with generalized myasthenia gravis. EudraCT: 2019-000968-18
Sponsor: UCB
Phase: III
Area: Neuromuscular disorders